+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hepatic and endocrine effects of azole antifungal agents



Hepatic and endocrine effects of azole antifungal agents



Chemotherapy of fungal diseases: 205-229



Hepatic and endocrine effects of azole antifungal agents, including nature of cytochrome P-450, mode of interaction of azoles with cytochromes P-450, effects of azoles on mammalian hepatic cytochromes P-450 and endocrine effects of azoles, particularly ketoconazole, are reviewed.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 001850591

Download citation: RISBibTeXText


Related references

Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains. Journal of Antimicrobial ChemoTherapy 42(6): 747-753, 1998

The combination effects of MDR inhibitors and azole antifungal agents against azole resistant Candida albicans strains. Clinical Infectious Diseases 25(2): 487, 1997

Disposition of azole antifungal agents. II. Hepatic binding and clearance of dichlorophenyl-bis-triazolylpropanol (DTP) in the rat. Pharmaceutical Research 11(7): 951-960, 1994

Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents. Drugs 79(8): 833-853, 2019

Comparison of the effects of azole antifungal agents on the anticoagulant activity of warfarin. Biological and Pharmaceutical Bulletin 37(12): 1990-1993, 2014

Comparison of the Effects of Azole Antifungal Agents on the Anticoagulant Activity of Warfarin. Biological & Pharmaceutical Bulletin 37(12): 1990-1993, 2014

A single amino acid substitution in the cytochrome P-450 lanosterol 14alpha-demethyalase from azole-resistant Cryptococcus neoformans clinical isolate contributed to resistance to azole antifungal agents. Abstracts of the General Meeting of the American Society for Microbiology 101: 370, 2001

Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrobial Agents and ChemoTherapy 42(2): 241-253, 1998

Different effects of azole-antifungal agents on ionomycin-response of intracellular calcium in Trichophyton rubrum. Journal of Investigative Dermatology 108(4): 664, 1997

Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiology and Immunology 40(11): 821-825, 1996

Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans. Diagnostic Microbiology and Infectious Disease 13(1): 31-35, 1990

Different effects of azole-antifungal agents on the regulation of intracellular calcium concentration of Trichophyton rubrum. Journal of Dermatological Science 12(2): 156-162, 1996

The role of azole antifungal agents for systemic antifungal therapy. Cleveland Clinic Journal of Medicine 64(2): 99, 1997

Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans. Antimicrobial Agents and ChemoTherapy 44(4): 1108-1111, 2000

Effects of azole antifungal agents on ionomycin-induced changes in intracellular calcium concentration in Trichophyton rubrum. Mycological Research 102(2): 193-198, 1998